Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Aimmune Therap

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Look Under The Hood: VB Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotechs Cruise On 6-Day Upswing Despite Price Target Cuts For This Duo
Biotech stocks cruised on a six-day upswing Monday despite price target cuts for Alkermes and Alder following their recent first-quarter earnings. 
Tags Technology
From Investor's Business Daily
BRIEF-Aimmune Therapeutics appoints Eric Bjerkholt as CFO
* Aimmune Therapeutics appoints Eric Bjerkholt as Chief Financial Officer 
Tags companyNews
From Reuters: Company News
First Week of AIMT May 19th Options Trading
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
Analysts See 13% Gains Ahead For The Holdings of PTH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Aimmune Therapeutics Q4 loss per share $0.55
* Aimmune Therapeutics announces fourth quarter and full year 2016 financial results 
Tags companyNews
From Reuters: Company News
Your Guide To 2017's Emerging Pharmaceuticals Catalysts
Wedbush’s Liana Moussatos mentioned a slew of potential catalysts that could impact emerging pharmaceutical companies this ... 
Tags Long Ideas Previews Liana Moussatos
From Benzinga
Aimmune Therapeutics Becomes Oversold (AIMT)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
13 Emerging Biotechs With Catalysts In 2017
Biotech stocks, which had a torrid 2016, can look ahead to the unfolding year with some hope, although given the quirky nature of the ... 
Tags Analyst Ratings UTHR Top Stories
From Benzinga
Peek Under The Hood: XBI Has 41% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Aimmune Therapeutics says Warren Desouza, notified co intention to leave his position as CFO of company on April 16
* Aimmune Therapeutics Inc- On December 8, Warren Desouza, notified co intention to leave his position of CFO of company on April 16, 2017- SEC filing Source text: [http://bit.ly/2gMnvfC] Further... 
Tags companyNews
From Reuters: Company News
BRIEF-Nestle Health Science Us Holdings reports 15.12 pct passive stake in Aimmune Therapeutics
* Nestle Health Science Us Holdings Inc reports 15.12 percent passive stake in Aimmune Therapeutics Inc as of November 23 - sec filing Source text : http://bit.ly/2fXFe0Z Further company coverage: 
Tags companyNews
From Reuters: Company News
BRIEF-Aimmune Therapeutics expects artemis to enroll 120-160 patients in Europe
* Aimmune Therapeutics completes global enrollment of phase 3 palisade trial of ar101 for the treatment of peanut allergy 
Tags companyNews
From Reuters: Company News
Commit To Buy Aimmune Therapeutics At $17.50, Earn 13.7% Annualized Using Options
Investors considering a purchase of Aimmune Therapeutics Inc (AIMT) stock, but tentative about paying the going market price of $24.99/share, might benefit from considering selling puts among the... 
Tags Stocks
From Market News Video
UPDATE 1-Nestle gets $145 mln stake in food allergy specialist Aimmune
ZURICH, Nov 4 (Reuters) - Nestle's Health Science unit will invest $145 million in U.S. food allergy specialist Aimmune Therapeutics, the latest move by the Swiss food giant in the health arena, the... 
Tags companyNews
From Reuters: Company News
Nestle invests $145 million in U.S. food allergy company Aimmune
ZURICH, Nov 4 (Reuters) - Nestle's Health Science unit will invest $145 million in U.S. food allergy company Aimmune Therapeutics, the latest move by the Swiss food giant in the health arena, the... 
Tags companyNews
From Reuters: Company News
Short Interest Jumps 14% For AIMT
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 303,740 share increase in total short interest for Aimmune Therapeutics Inc (AIMT), to 2,475,743,... 
Tags Stocks
From Market News Video
Hottest Manufacturing Stocks Now – SPHS WINT MTP AIMT
 
Tags AMEX:PFNX NASDAQ:MTP NASDAQ:IMMR
From InvestorPlace
Commit To Purchase Aimmune Therapeutics At $10, Earn 11.9% Annualized Using Options
Investors considering a purchase of Aimmune Therapeutics Inc (AIMT) shares, but cautious about paying the going market price of $13.39/share, might benefit from considering selling puts among the... 
Tags Stocks
From Market News Video
BRIEF-Aimmune Therapeutics says reaffirming its 2016 financial guidance
* Aimmune Therapeutics announces second quarter 2016 financial results 
Tags companyNews
From Reuters: Company News
Aimmune Therapeutics Stock Sees Short Interest Expand By 14%
The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 266,880 share increase in total short interest for Aimmune Therapeutics Inc (AIMT), to 2,172,003,... 
Tags Stocks
From Market News Video
Peek Under The Hood: IWO Has 13% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biggest Movers in Manufacturing Stocks Now – RXII VTGN AXSM SHLO
 
Tags NASDAQ:IMDZ NASDAQ:CYCC NASDAQ:AXSM
From InvestorPlace
Hottest Manufacturing Stocks Now – MNI EBIO VBLT HSGX
 
Tags NASDAQ:DMTX NYSE:TROX NASDAQ:EBIO
From InvestorPlace
Stocks Hitting 52-Week Lows
CVR Refining LP (NYSE: CVRR) shares fell 1.25 percent to touch a new 52-week low of $8.69. CVR Refining shares have dropped 53.49 ... 
Tags AIMT Markets Intraday Update
From Benzinga
BRIEF-Aimmune Therapeutics announces data supporting safety, tolerability profile of AR101
* Data from AR101 for peanut allergy showed safety and tolerability profile improved with continued treatment 
Tags companyNews
From Reuters: Company News
Surprising Analyst 12-Month Target For EQWS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Aimmune Therapeutics reports Q1 loss of $0.37 per share
* Fy2016 earnings per share view $-1.68, revenue view $0.00 -- Thomson Reuters I/B/E/S 
Tags companyNews
From Reuters: Company News
Analysts Forecast 10% Upside For The Holdings of RSCO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aimmune Therapeutics Reports Discussed Phase 2 Data on AR101 for Treatment of Peanut Allergy at FARE Research Retreat
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ... 
Tags AIMT Benzinga Press Releases
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback